Pre-analysis for hemostatic effect of bypassing agents in hemophilia a patients with inhibitors under the emicizumab prophylaxis by global assays

Category Primary study
JournalBlood
Year 2018
This article has no abstract
Epistemonikos ID: 0aabbed039b1b355aebecca7caa738145bf843e8
First added on: Feb 10, 2025